Ipsos & Amgen Named Finalists in the BHBIA BOBI Awards 2014/15

Ipsos Healthcare, Ipsos and biopharma company, Amgen, have been named finalists in the ‘Most Innovative Approach’ category of the BHBIA BOBI Awards 2014-15.

Ipsos Healthcare, Ipsos and biopharma company, Amgen, have been named finalists in the ‘Most Innovative Approach’ category of the BHBIA BOBI Awards 2014-15.

The short-listing is for our global syndicated ethnographic study, ‘Cultures of Secrecy and Hiding: a Global Syndicated Ethnographic Investigation into Patients Living With Psoriasis'.

The uniqueness of the study comes in many forms: its ethnographic video approach when Psoriasis patients are difficult to engage due to the sensitivity of their condition; the fact it is syndicated and offers efficient access to these hard to reach patients; and its focus on the patients’ own experience of living with their disease rather than the doctors’ perspective. This innovative study was awarded the Grand Prix for Greatest Impact Award and the Award for Healthcare Research at the MRS Awards 2014.

Related news